Cancer Therapy, Oncology Services | Precision Therapeutics

CONTACT US \| EMPLOYEE LOG IN \| CLIENT SERVICES \| GLOSSARY \| SITE MAP

Precision Therapeutics is an oncology services company dedicated to the individualization of cancer therapy. Precision is a leader in the development and delivery of treatment support tools that assist physicians and benefit cancer patients.

What makes ChemoFx
Assay different?

ChemoFx is a cell-based test that examines the likelihood of specific patient's tumor response to a broad range of existing, novel and combination chemotherapies. ChemoFx provides a direct insight into which chemotherapy regimens may be most effective for each patient.
READ MORE »

My most pressing patient was a 28-year-old woman who had recurrent ovarian cancer and was actually near death's door at the time of a surgery for an intestinal blockage.
READ MORE »

She has had an amazing recovery in the last three months and is now eating and almost ready for discharge home to her 7-year-old daughter and her husband who eagerly await her return.
READ MORE »

Precision is committed to high-integrity research into the development of individualized cancer treatment support tools and services. Click here for more information on our clinical trials program.
READ MORE »

NEWS & EVENTS

Precision's Quarterly Newsletter

April 2008
READ MORE »

April 8 , 2008

Precision Adds 8 Million Covered Lives Under Contract

March 4, 2008

Merger Plan Terminated

February 22, 2008

Oracle Healthcare and Precision Merger Plan Amended

December 4, 2007

Oracle Healthcare and Precision Therapeutics announce Merger

October, 2007
Precision announces study results with independent cytopathologist
READ MORE »

PUBLICATIONS

A significant body of research exists supporting the science and technology behind ChemoFx and exploring other issues related to individualized chemotherapy treatments. We've compiled much of it, including works by Precision Therapeutics researchers, in our Bibliography & Publications section.REVIEW THE RESEARCH »